- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05578742
V/Q Matching Variations With PEEP in ARDS According to Compliance-based Phenotypes (France) (MISMATCHED FR)
Effect of PEEP on Ventilartion/Perfusion Ratios According to Different Phenotypes in Patients With ARDS (France)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute Respiratory Distress Syndrome (ARDS) is characterized by hypoxemia caused by inflammatory lung injury. Recent studies showed an important variability in ARDS phenotypes . The recent COVID-19 crisis highlighted the presence of ARDS patients with severe hypoxemia and normal respiratory system compliance, and retrospective series confirmed the existence of this atypical ARDS pattern also in non-COVID etiologies.
The dissociation between mechanics and hypoxemia may be related to a specific diversity in the pattern of ventilation-perfusion matching (V/Q matching) among patients with normal compliance and ARDS. In patients with low compliance, V/Q mismatch may be characterized by right-to-left shunt, secondary to collapse of the gravity-dependent regions; while, in patients with normal compliance, V/Q mismatch may show a redistribution of blood flow to hypo-ventilated lung areas by larger dead space and impaired hypoxic vasoconstriction.
These differences may also influence the response to PEEP in terms of gas exchange and lung protection . It may also explain the failure for high PEEP levels to improve significantly mortality in the global ARDS population (i.e., with patients' selection only based on hypoxemia).
Electrical Impedance Tomography (EIT) is a device allowing to assess ventilation and perfusion distribution. Thus, EIT can be used to evaluate global and regional V/Q matching, and could be used to understand mechanisms of hypoxemia, especially in patients with normal mechanics and ARDS.
The aim of this study is to assess V/Q matching according to these different ARDS phenotypes, and to evaluate the effects of PEEP in each one.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: François Beloncle, MD
- Phone Number: +33 241 35 58 65
- Email: francois.Francois.Beloncle@chu-angers.fr
Study Contact Backup
- Name: UH Angers DRCI
- Phone Number: +33 2 41 35 54 96
- Email: DRCI-Promotion-Interne@chu-angers.fr
Study Locations
-
-
Maine et Loire
-
Angers, Maine et Loire, France, 49933
- Recruiting
- Angers Hospital
-
Contact:
- François Beloncle, MD
- Phone Number: +33 2 41 58 65
- Email: Francois.Beloncle@chu-angers.fr
-
Contact:
- UH Angers DRCI UH Angers
- Phone Number: +33 5 41 35 54 96
- Email: DRCI-Promotion-Interne@chu-angers.fr
-
Principal Investigator:
- francois beloncle, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- intubated patients with moderate and severe ARDS (Berlin definition, PaO2/FiO2 ≤200 mmHg at PEEP 5 cmH2O)
- undergoing deep sedation
- on controlled mechanical ventilation
- between 24 hours and 5 days after intubation.
Exclusion criteria:
- age <18 years old; pregnancy
- patient undergoing legal protection
- contra-indications to EIT (e. g. severe chest trauma or wounds)
- pneumothorax; patient undergoing ECMO
- patient with BMI ≥35 kg/m2
- hemodynamic instability with MAP <60 mmHg despite vasopressors.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Strategy A: PEEP 15 cmH2O → PEEP 5 cmH2O
|
Positive End Expiratory Pressure (PEEP) will be decreased from 15 to 5 cmH2O.
|
|
Active Comparator: Strategy B: PEEP 5 cmH2O → PEEP 15 cmH2O
|
Positive End Expiratory Pressure (PEEP) will be increased from 5 to 15 cmH2O.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in ventilation/perfusion mismatch between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
Ventilation/perfusion (V/Q) mismatch will be assessed by Electrical Impedance Tomography (EIT).
Mismatch is expressed in %.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in respiratory mechanics between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
Plateau pressure and total PEEP will be aggregated to compute driving pressure (Plateau pressure minus total PEEP, all in cmH2O).
Respiratory system compliance will be computed by dividing tidal volume by driving pressure (in mL.cmH2O-1; respiratory system resistance will be computed as the inverse of compliance; all these values will be assessed and compared between the two PEEP levels.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
|
Difference in oxygenation between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
PaO2 (in mmHg) will be assessed and compared between the two PEEP levels.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
|
Difference in carbon clearance between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
PaCO2 (in mmHg) will be assessed and compared between the two PEEP levels.
Ventilatory ratio (no unit) will be derived from the PaCO2 values.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
|
Difference in dead space measured by capnometric volumetry between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
VCO2 (measured by Vcap, in mmHg) will be assessed and compared between the two PEEP levels.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
|
Difference in dead space measured by calorimetry between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
VCO2 (measured by calorimetry, in mmHg) will be assessed and compared between the two PEEP levels.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
|
Difference in venous oxygen saturation between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
SvO2 (in %) will be assessed and compared between the two PEEP levels.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
|
Correlation between V/Q mismatch markers and recruitability
Time Frame: immediately after each intervention
|
Recruitability will be assessed between 15 and 5 cmH2O by respiratory mechanics and EIT, as the recruited volumes value (in mL).
R/I ratio will be derived from these data (no unit).
V/Q mismatch will be computed by EIT, and expressed in %.
Correlation will be performed by linear regression.
|
immediately after each intervention
|
|
Correlations between V/Q mismatch assessed by EIT and dead space markers
Time Frame: immediately after each intervention
|
Dead space will be assessed by volumetric capnography (if available), venrtilatory ratio, and calorimetriy (if available).
V/Q mismatch will be computed by EIT, and expressed in %.
Correlation will be performed by linear regression.
|
immediately after each intervention
|
|
Correlations between V.Q mismacth and overdisension and lung collapsus
Time Frame: immediately after each intervention
|
Overdistension (%) and lung collapsus (%) will be assessed during the Step 3, by EIT.
These two values cannot be measured separately.
V/Q mismatch will be computed by EIT, and expressed in %.
Correlation will be performed by linear regression.
|
immediately after each intervention
|
|
Difference in stress index between PEEP 5 and 15 cmH2O according to the two studied phenotypes
Time Frame: immediately after each intervention
|
stress index (no unit) will be assessed and compared between the two PEEP levels.
Comparison between phenotype with higher and lower elastance will be performed.
|
immediately after each intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-A00649-34
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ARDS
-
Guy's and St Thomas' NHS Foundation TrustRecruiting
-
University Hospital, Clermont-FerrandAZUREA groupCompleted
-
West China HospitalCompleted
-
Pamukkale UniversityCompleted
-
Southeast University, ChinaActive, not recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Hamilton Medical AGTerminated
-
Southeast University, ChinaUnknown
-
University of TorontoSunnybrook Health Sciences Centre; Unity Health TorontoCompleted
-
Southeast University, ChinaRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
Clinical Trials on PEEP decrease
-
University of Alabama at BirminghamRecruitingBronchopulmonary Dysplasia | Ventilation Perfusion Mismatch | Ventilator Lung; Newborn | Extreme Prematurity | Pulmonary Hypertension Due to Lung Diseases and HypoxiaUnited States
-
University of BariCompleted
-
Institute for Mother and Child Health Care of Serbia...Completed
-
Northwestern UniversityCompletedObesity | Binge EatingUnited States
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Al-Azhar UniversityCompletedPulmonary Atelectasis, PostoperativeEgypt
-
Gachon University Gil Medical CenterCompletedThe Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy (lapaPEEP)Brain IschemiaKorea, Republic of
-
Ankara City Hospital BilkentNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications | Impaired Oxygenation
-
University Hospital, Basel, SwitzerlandRecruiting
-
Mansoura UniversityCompletedOne Lung VentilationEgypt